FDHT
Fidelity Digital Health ETF
FDHT tracks a market-cap-weighted index of globally-listed companies involved in digital health technologies.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 6.6 M
ASSETS UNDER MGMT
39 bp
EXPENSES
Fund Basics
| Inception date | Oct 05, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| INTUITIVE SURGICAL INC | 5.9 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 5.2 % |
| KONINKLIIJKE ELECTRONICS NV | 4.6 % |
| SIEMENS HEALTHINEERS AG | 3.9 % |
| VEEVA SYSTEMS INC-CLASS A | 3.9 % |
| INSULET CORP | 3.9 % |
| DEXCOM INC | 3.9 % |
| FISHER & PAYKEL HEALTHCARE CORPORATION L | 3.7 % |
| JD HEALTH INTERNATIONAL, INC. | 2.7 % |
| PRO MEDICUS LIMITED | 2.6 % |
Constituent Breakdown
| Number of holdings | 65 |
| Herfindahl-Hirschman Index | 261 |
| Wgt avg mkt cap (mns) | $120,945 |
| Large cap (>$10bn) | 46.3% |
| Mid cap ($2-10bn) | 18.5% |
| Small cap (<$2bn) | 23.4% |
| Developed mkts. | 86.4% |
| Emerging mkts. | 4.8% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 61.5 % |
 |
NETHERLANDS | 5.9 % |
 |
CHINA | 4.8 % |
 |
GERMANY | 3.9 % |
 |
NEW ZEALAND | 3.7 % |
 |
AUSTRALIA | 3.5 % |
 |
JAPAN | 2.6 % |
 |
HONG KONG | 1.9 % |
 |
BRITAIN | 1.5 % |
 |
SWEDEN | 1.1 % |
Historical Performance
Standardized Performance (as of 12/31/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 2.4% | 2.4% | 1.4% | 2.4% | -- | -- | -- | -5.1% |
| Dividend Yield | 1.3% | 1.3% | 1.4% | 1.0% | -- | -- | -- | 0.7% |
| Total Returns | 3.7% | 3.7% | 2.9% | 3.4% | -- | -- | -- | -4.5% | Ann. Volatility | 21.1% | 21.1% | 19.1% | 19.2% | -- | -- | -- | 22.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.80 | 65% |
| MSCI EAFE | 0.94 | 62% |
| MSCI Emg Mkts | 0.83 | 54% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.6% |
| Avg. Bid/Ask (% of price) | 0.30% |
Technical Indicators
| 30d moving avg. (EMA) | $20.82 |
| Relative strength (RSI) | 40 |
| MACD/Signal | -0.33/-0.25 |
| Bollinger Bands (Upper/Lower) | $22.02/$19.67 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. FDHT |
Expenses vs. FDHT |
ALTAR Score™ vs. FDHT |
|---|---|---|---|---|
| HEAL | Global X HealthTech ETF | 48.3% | +11 bp | -2.8% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 26.7% | +26 bp | -1.0% |
| IHI | iShares U.S. Medical Devices ETF | 18.0% | +1 bp | +2.8% |
| FMED | Fidelity Disruptive Medicine ETF | 17.0% | +11 bp | -3.4% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 16.8% | -4 bp | +1.6% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 16.6% | +29 bp | +0.2% |
| MDEV | First Trust Indxx Medical Devices ETF | 14.7% | +31 bp | +2.9% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 11.8% | +36 bp | -0.8% |
Risk and Returns: FDHT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/17/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
2.2%
ALTAR SCORE™
21st
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 586 funds in the Global Equity category with an average
ALTAR Score™ of 4.4% and a standard deviation
of 2.6%. FDHT's ALTAR Score™ is approximately -0.8 standard
deviations above the category average. This places FDHT in the 21st percentile
among funds in the category.
Sell-Side Consensus
$29.13
PRICE TARGET
+45.7%
UPSIDE